Definitive Healthcare (NASDAQ:DH) Trading Down 4.9% – Time to Sell?

Definitive Healthcare Corp. (NASDAQ:DH)’s share price fell 4.9% during mid-day trading on Wednesday . The stock traded as low as $4.76 and last traded at $4.77. 104,155 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 756,992 shares. The stock had previously closed at $5.01.

Analysts Set New Price Targets

Several research firms have recently issued reports on DH. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Stephens began coverage on shares of Definitive Healthcare in a report on Friday, December 20th. They set an “equal weight” rating and a $5.00 price target for the company. Finally, Barclays reaffirmed an “underweight” rating and set a $4.00 price target on shares of Definitive Healthcare in a report on Monday, January 13th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $5.72.

Definitive Healthcare Stock Performance

The stock has a market capitalization of $568.94 million, a P/E ratio of -1.59, a P/E/G ratio of 3.54 and a beta of 1.41. The company’s 50-day moving average is $4.38 and its two-hundred day moving average is $4.45. The company has a current ratio of 2.49, a quick ratio of 2.49 and a debt-to-equity ratio of 0.33.

Definitive Healthcare (NASDAQ:DH) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.03). Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The company had revenue of $62.70 million during the quarter, compared to analyst estimates of $61.66 million. During the same quarter last year, the business earned $0.01 EPS. As a group, sell-side analysts anticipate that Definitive Healthcare Corp. will post 0.15 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider William Moschella sold 45,000 shares of the stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the sale, the insider now owns 433,830 shares in the company, valued at $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 14.84% of the company’s stock.

Hedge Funds Weigh In On Definitive Healthcare

A number of hedge funds have recently added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA raised its position in shares of Definitive Healthcare by 36.8% in the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after purchasing an additional 1,626,813 shares during the period. Millennium Management LLC bought a new position in shares of Definitive Healthcare in the second quarter valued at approximately $9,283,000. State Street Corp raised its position in shares of Definitive Healthcare by 29.4% in the third quarter. State Street Corp now owns 1,399,729 shares of the company’s stock valued at $6,257,000 after purchasing an additional 317,952 shares during the period. 272 Capital LP boosted its stake in Definitive Healthcare by 74.8% during the third quarter. 272 Capital LP now owns 1,114,080 shares of the company’s stock worth $4,980,000 after buying an additional 476,766 shares in the last quarter. Finally, Victory Capital Management Inc. boosted its stake in Definitive Healthcare by 6.5% during the third quarter. Victory Capital Management Inc. now owns 542,170 shares of the company’s stock worth $2,424,000 after buying an additional 33,161 shares in the last quarter. Institutional investors and hedge funds own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.